Altra Inc.'s Life‑Saving Infusion Therapy for the Battlefield

Altra Inc. – Life‑Saving Infusion Therapy for the Battlefield

Altra Inc., founded in 2012, is re‑engineering infusion therapy from the ground up with a focus on battlefield support. Based in the U.S., the company has developed its next‑generation AQGuard Infusion System to address the root causes of adverse events in drug delivery—mechanical failures, flow irregularities, false alarms, air‑in‑line errors and occlusion detection delays. These issues continue to plague conventional pumps. While many pump systems are optimized for static hospital settings, Altra has invested a decade of development and has invented new fluid control technology.Deliberately designed its system for mobility, rugged durability, precision and versatility, it is built to work in first‑responder units, home care and importantly for military field and transport operations.

Technology Highlights

• Dual‑chamber hydraulic pumping design yields extraordinarily high precision and accuracy exceeding all conventional pumps in performance.
• Rapid occlusion detection (in seconds, not minutes) and advanced air‑in‑line detection system eliminate major causes of pump failures and more quickly alert nurses to potentially life-threatening situations.
• Head‑height independence, extended battery life, low power consumption, rugged waterproof form factor for field deployment, low to no maintenance.
• Cost‑effective cassette/component design aimed at scalable manufacture with lower cost and higher reliability.

These features make Altra’s smart infusion pump uniquely suited to battlefield, en‑route and austere settings where standard infusion pumps struggle—and where lives are on the line.

Relevance for Battlefield & En‑Route Care

In military and combat casualty care, the window to deliver critical infusions—fluids, blood products, vasopressors—is extremely constrained by environment, movement, terrain and transport conditions. A pump that fails, alarms falsely, misloads or suffers a mechanical fault simply isn’t good enough. Because Altra’s system is purpose‑built to work anywhere, with durability, simplicity and precision, it is ideally positioned as a life‑saving platform for field medical units, forward surgical teams, aeromedical evacuation and casualty evacuation vehicles.

MTEC Bridge Loan Award & Why It Matters

Through MTEC’s Prototype Acceleration Bridge Loan program, Altra secured a bridge‑loan award under the 'Prototype Acceleration Bridge Loans' solicitation. This program offers loans of roughly $50K‑$100K to de‑risk device maturation toward military application and prime follow‑on funding. This award is a strong signal: it validates that Altra’s design meets the readiness and application profile that MTEC supports—forward/deployed medical technologies—and provides a bridge to commercially mature follow‑on funding, helping accelerate Altra’s pathway to field‑deployable military infusion solutions. Altra is using this funding to continue prototype refinement and add staff from successful medical technology product launches.

Call to Investors

For investors looking for a high‑impact opportunity at the intersection of medtech, defense and trauma care, Altra offers a compelling proposition:

• An advanced technology platform addressing a large, underserved infusion market with military and emergency‑care applications.
• Early validation via MTEC’s bridge‑loan program, de‑risking development and opening pathway to larger contracts.
• A life‑saving mission: supporting wounded soldiers, first responders and casualty evacuation chains with a pump that won’t fail when seconds matter.

We invite you to consider joining Altra’s journey—investing in a company that literally stands between life and death in the field, and in a technology built from the ground up for the harshest environments. With Altra, you are not just investing in med‑device innovation—you are investing in mission‑critical medical capability.

Contact:

Robert Canfield

Chief Product Officer

Altra, Inc.

619.325.9106

Robert@AltraInfusion.com

altrainfusion.com